Indication

Malignant neoplasm of liver

A malignant neoplasm of the liver is a cancerous tumor originating within hepatic tissue, most commonly presenting in adult populations as hepatocellular carcinoma or intrahepatic cholangiocarcinoma. Read more about Malignant neoplasm of liver

4 drugs 4 manufacturers

Advertisement

Drugs that treat it

Common Malignant neoplasm of liver therapies.

Showing 1–4 of 4 drugs

FLOXURIDINE

MALIGNANT NEOPLASM OF LIVER·+1
APP PHARMACEUTI

FLOXURIDINE

MALIGNANT NEOPLASM OF LIVER·+1
APP/FRESENIUS K

FLOXURIDINE

MALIGNANT NEOPLASM OF LIVER·+1
Hikma Pharmaceuticals USA

FLOXURIDINE

5 FLUOROPYRIMIDINES·MALIGNANT NEOPLASM OF LIVER·+1
JND THERAPEUTIC
Filter & compare in the drug finder →Opens the drug finder with Malignant neoplasm of liver preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Malignant neoplasm of liver.

A malignant neoplasm of the liver is a cancerous tumor originating within hepatic tissue, most commonly presenting in adult populations as hepatocellular carcinoma or intrahepatic cholangiocarcinoma.

Pathophysiologically, these malignancies typically arise in the setting of chronic hepatic inflammation, injury, and cirrhosis driven by risk factors such as chronic hepatitis B or C infection, alcohol-related liver disease, or metabolic dysfunction-associated steatotic liver disease.

Malignant transformation leads to uncontrolled cellular proliferation, architectural disruption of hepatic parenchyma, and potential vascular invasion into the portal or hepatic venous systems.

Clinical manifestations often emerge at advanced stages and include right upper quadrant abdominal pain, hepatomegaly, unexplained weight loss, ascites, and worsening hepatic decompensation or jaundice.

Personalize your experience

Follow Malignant neoplasm of liver and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it